Authors: Developed by the Training Working Group within Veeva’s Site Advisory Council.

Purpose: To assess the quality and effectiveness of SIV training, identify improvement opportunities, and confirm site readiness to conduct the protocol compliantly.

Methodology: This two-phase survey correlates initial "Readiness Gaps" and initial patient enrollment, to identify how early training impacts downstream clinical performance in interventional clinical trials (drug or device).
  • Phase I: Baseline Readiness Assessment – Post Site Initiation Visit (SIV), this phase captures immediate perceptions of training clarity alongside the site’s self-reported confidence in executing critical protocol tasks.
  • Phase II: Performance & Quality Correlation – Conducted post subject screening/enrollment, this phase tracks actual protocol deviations, safety reporting accuracy, and data queries.
Confidentiality: Responses will be used for quality improvement and reviewed for data analysis. All survey responses and findings will be anonymized and shared without identifying any specific sponsor, CRO, site or contributor.
 
 12% of survey complete.

T